| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 39.78M | 42.96M | 43.92M | 49.13M | 60.01M |
| Gross Profit | 29.25M | 31.79M | 32.75M | 36.47M | 44.99M |
| EBITDA | -458.00K | -1.17M | -1.51M | -66.00K | 1.87M |
| Net Income | -882.00K | 572.00K | 568.00K | 313.00K | 1.08M |
Balance Sheet | |||||
| Total Assets | 38.43M | 55.36M | 69.09M | 82.82M | 98.36M |
| Cash, Cash Equivalents and Short-Term Investments | 28.87M | 43.94M | 56.18M | 69.67M | 83.84M |
| Total Debt | 3.13M | 2.64M | 3.46M | 4.12M | 3.17M |
| Total Liabilities | 15.00M | 22.49M | 27.49M | 32.67M | 38.87M |
| Stockholders Equity | 23.43M | 32.87M | 41.60M | 50.15M | 59.49M |
Cash Flow | |||||
| Free Cash Flow | -6.07M | -3.42M | -4.32M | -5.00M | 791.00K |
| Operating Cash Flow | -6.00M | -3.37M | -4.28M | -4.85M | 1.02M |
| Investing Cash Flow | 8.15M | -30.07M | -46.00K | -143.00K | -225.00K |
| Financing Cash Flow | -9.21M | -9.21M | -9.21M | -9.14M | -9.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | $28.22M | -43.29 | -0.38% | 25.20% | -5.07% | -115.50% | |
49 Neutral | $19.16M | 16.10 | -11.43% | ― | -12.53% | -3.24% | |
44 Neutral | $24.26M | -1.03 | ― | ― | -10.64% | 37.38% | |
44 Neutral | $1.21M | -0.01 | -8.68% | ― | -74.20% | 64.28% |
On February 17, 2026, Natural Health Trends repurchased all 2,935,227 shares of its common stock beneficially owned by the George K. Broady family trusts in a privately negotiated deal. The block, equal to about 25.5% of outstanding shares, was bought for $2.00 per share, or roughly $5.9 million in total, funded entirely from existing cash and approved by a special board committee.
The transaction, executed under the company’s $70 million share repurchase program, reduces the share count to 8,577,848 and leaves about $16 million available for future buybacks under the plan. Management highlighted that retiring this large, non-float block removes perceived stock overhang, avoids potential market disruption, cuts annual dividend obligations by about $1.2 million at the current rate and is intended to enhance value and liquidity for remaining shareholders while the long-time investor exits for personal financial reasons.
The most recent analyst rating on (NHTC) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Natural Health Trends stock, see the NHTC Stock Forecast page.